Saudi Arabia
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
10.52%
|
Dec. 31, 2023 | USD 8.71 | -0.52% |
|
Saudi Arabia |
The Clinical Trials company in Saudi Arabia with the highest EBITDA Margin is Saudi Pharmaceutical Industries and Medical Appliances Corporation (Saudi Stock Exchange: 2070.SR) at 10.52%.
The Clinical Trials company in Saudi Arabia with the lowest EBITDA Margin is Saudi Pharmaceutical Industries and Medical Appliances Corporation (Saudi Stock Exchange: 2070.SR) at 10.52%.
The top 10 Clinical Trials companies in Saudi Arabia by EBITDA Margin are and Saudi Pharmaceutical Industries and Medical Appliances Corporation.
The bottom 10 Clinical Trials companies in Saudi Arabia by EBITDA Margin are and Saudi Pharmaceutical Industries and Medical Appliances Corporation.